Usefulness of histopathological markers in diagnosing Barrett's intraepithelial neoplasia (dysplasia)

Acta Gastro-Enterologica Belgica

Volumn 72, Issue 4, 2009, Pages 425-432

  Jouret Mourin, A ^a   Sempoux, C ^a   Ho Minh Duc, K ^a   Geboes, K ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

AMACR; Barrett; Dysplasia; Intraepithelial neoplasia; Ki67; p53

Indexed keywords

A METHYLCOENZYME A RACEMASE; BIOLOGICAL MARKER; KI 67 ANTIGEN; PROTEIN P53; RACEMASE; UNCLASSIFIED DRUG;

BARRETT ESOPHAGUS; CANCER RISK; CELL COUNT; CLINICAL ASSESSMENT; CONFERENCE PAPER; DISEASE SEVERITY; DNA CONTENT; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; EUROPE; FLOW CYTOMETRY; FOLLOW UP; GENETICS; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTRAEPITHELIAL NEOPLASIA; MEDICAL LITERATURE; MORPHOLOGICAL TRAIT; MORPHOMETRICS; NEOPLASM; PROTEIN EXPRESSION; REPRODUCIBILITY; SAMPLING; SOCIOECONOMICS; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS;

BARRETT ESOPHAGUS; CARCINOMA IN SITU; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; KI-67 ANTIGEN; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 76049116206     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. ODZE R.D. Update on the diagnosis and treatment of Barrett esophagus and related neoplastic precursor lesions. Arch. Pathol. Lab. Med., 2008, 132 : 1577-1585.
2. GEBOES K., VAN EYKEN P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology, 2000, 37 : 99-107.
3. RIDDELL R.H., GOLDMAN H., RANSOHOFF D.F., APPELMAN H.D., HAGGITT R.C., AHREN C., CORREA P., HAMILTON R.C., MORSON B.C. Dysplasia in IBD : standardized classification with provisional clinical applications. Hum. Pathol., 1983, 14 : 931-968.
4. SCHLEMPER R.J., RIDDELL R.H., KATO Y., BORCHARD F., COOPER H.S., DAWSEY S.M., DIXON M.F., FENOGLIO-PREISER C.M., FLEJOU J.F., GEBOES K., HATTORI T., HIROTA T., ITABASHI M., IWAFUCHI M., IWASHITA A., KIM Y.I., KIRCHNER T., KLIMPFINGER M., KOIKE M., LAUWERS G.Y., LEWIN K.J., OBERHUBER G., OFFNER F., PRICE A.B., RUBIO CA., SHIMIZU M., SHIMODA T., SIPPONEN P., SOLCIA E., STOLTE M., WATANABE H., YAMABE H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut, 2000, 47 : 251-255.
5. OFFERHAUS G.J.A., CORREA P., VAN EEDEN S.., GEBOES K., DRILLENBURG P., VIETH M., VAN VELTHUYSEN M.L., WATANABE H., SIPPONEN P., TEN KATE F.J., BOSMAN F.T., BOSMA A., RISTlMAKI A., VAN DEKKEN H., RIDDELL R., TYTGAT G.N. Report of an Amsterdam Working group on Barrett esophagus. Virchows Arch., 2003, 443 : 601-607.
6. WERNER M., FLEJOU J.F., HAINAUT P. In : Pathology and Genetics of the Digestive System. IARC Press Lyon, 2000, 20-26.
7. MONTGOMERY E., GOLDBLUM J.R., GREENSON J.K., HABER M.M., LAMPS L.W., LAUWERS G.Y., LAZENBY A.J., LEWIN D.N., ROBERT M.E., WASHINGTON K., ZAHURAK M.L., HART J. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus : a follow-up study based on 138 cases from a diagnostic variability study. Hum. Pathol., 2001, 32 : 379-388.
8. HORNICK J.L., ODZE R.D. Neoplastic precursor lesions in Barrett's esophagus. Gastroenterol. Clin. N. Am., 2007, 36 : 775-796.
9. REID B.J., HAGGITT R.C., RUBIN C.E., ROTH G., SURAWICZ C.M., VAN BELLE G., LEWIN K., WEINSTEIN W.M., ANTONIOLI D.A., GOLDMAN H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol., 1988, 19 : 166-178.
10. LAUWERS G., RIDDELL B. Gastric epithelial dysplasia. Gut, 1999, 45: 784-790.
11. LOMO L.C., BLOUNT P.L., SANCHEZ C.A., LI X., GALlPEAU P.C., COWAN D.S., AYUB K., RABINOVITCH P.S., REID B.J., ODZE R.D. Crypt dysplasia with surface maturation : a clinical, pathological and molecular study of a Barrett's esophagus cohort. Am. J. Surg. Pathol., 2006, 30 : 423-435.
12. FLEJOU J.F. Histological assessment of oesophageal columnar mucosa. Best Pract. Res. Clin.Gastroenterol., 2008, 22 : 671-686.
13. MONTGOMERY E., BRONNER M.P., GOLDBLUM J.R., GREENSON J.K., HABER M.M., HART J., LAMPS L.W., LAUWERS G., LAZENBY A.J., LEWIN D.N., ROBERT M.E., TOLEDANO A.Y., SHYR Y., WASHINGTON K. Reproducibility of the diagnosis of dysplasia in Barrett oesophagus : a reaffirmation. Hum. Pathol., 2001, 32 : 368-378.
14. KERKHOF M., VAN DEKKEN H., STEYERBERG E.W., MEIJER G.A., MULDER A.H., DE BRUINE A., DRIESSEN A., TEN KATE F.J., KUSTERS J.G., KUIPERS E.J., SIERSEMA P.D. Grading of dysplasia in Barrett's oesophagus : substantial interobserver variation between general and GI pathologists. Histopathology, 2007, 50 : 920-927.
15. KAYE P.V., HAIDER S.A., ILYAS M., JAMES P.D., SOOMRO I., FAISAL W., CATTON J., PARSONS S.L., RAGUNATH K. Barrett's dysplasia and the Vienna classification : reproductibility prediction of progression and impact of consensus reporting and p53 immunochemistry. Histopathology, 2009, 54 : 699-712.
16. PECH O., VIETH M., SCHMITZ D., GOSSNER L., MAY A., SEITZ G., STOLTE M., ELL C. Conclusions from histological diagnosis of low grade intraepithelial neoplasia in Barrett's oesophagus. Scand. J. Gastroenterol., 2007, 42 : 682-688.
17. SKACEL M., PETRAS R.E., GRAMLICH T.L., SIGEL J.E., RICHTER J.E., GOLDBLUM J.R. The diagnosis of low grade dysplasia in Barrett's esophagus and its implications for disease progression. Am. J. Gastroenterol., 2000, 95 : 3383-3387.
18. FLEJOU J.F., SVRCEK M. Barrett's oesophagus- a pathologist's view. Histopathology, 2007, 50 : 3-14.
19. PRESTON S.L., JANKOWSKI J.A. Drinking from the fountain of promise : biomarkers in the surveillance of Barrett's esophagus - the glass is half full ! Gut, 2006, 55 : 1377-1379.
20. REID B.J., BLOUNT P.L., RABINOVITCH P.S. Biomarkers in Barrett's oesophagus. Gastrointest. Endosc. Clin. N. Am., 2003, 13 : 369-397.
21. POLKOWSKI W., BAAK J.P., VAN LANSCHOT J.J. Clinical decision making in Barrett's oesophagus can be supported by computerized immuno-quantification and morphometry of features associated with proliferation and differentiation. J. Pathol., 1998, 184: 161-168.
22. BAAK J.P., TEN KATE F.J., OFFERHAUS G.J., VAN LANSCHOT J.J., MEIJER G.A. Routine morphological analysis can improve reproductibility of dysplasia grade in Barrett's oesophagus surveillance biopsies. J. Clin. Pathol., 2002, 55 : 910-916.
23. REID B.J., LEVINE D.S., LONGTON G., BLOUNT P.L., RABINOVITCH P.S. Predictors of progression to cancer in Barrett's esophagus baseline histology and flow cytometry indentify low and high risk patients subsets. Am. J. Gastroenterol., 2000, 95 : 1669-1676.
24. RABINOVITCH G., LONGTON G., BLOUNT P.L., RABINOVITCH P.S., LONGTON G., BLOUNT P.L., LEVINE D.S., REID B.J. Predictors of progression in Barrett's esophagus baseline flow cytometric variables. Am. J. Gastroenterol., 2001, 96 : 3071-3083.
25. FEITH M., STEIN H.J., MUELLER J., SIEWERT J.R. Malignant degeneration of Barrett's esophagus : the role of the Ki67 proliferation fraction, expression of E Cadherin and p53 . Dis. Esophagus, 2004, 17 : 322-327.
26. OLVERA M., WICKRAMASINGHE K., BRYNES R., BU X., MA Y, CHANDRASOMA P. KI67 expression in different epithelial types in columnar lined oesophagus indicates varying levels of expanded and aberrant proliferative patterns. Histopathology, 2005, 47: 132-140.
27. HONG M.K., LASKIN W.B., HERMAN B.E., JOHNSTON M.H., VARGO J.J., STEINBERG., ALLEGRA C.J., JOHNSTON P.G. Expansion of the KI67 proliferative compartment correlates with degree of dysplasia in Brrett's oesophagus. Cancer, 1995, 75 : 423-429.
28. LÖRING E., JAKOBSSON B., LANDBERG G., VERESS B. KI67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus. Histopathology, 2005, 46 : 642-648.
29. WHITTLES C.E., BIDDLESTONE L.R., BURTON A., BARR H., JANKOWSKI J.A., WARNER P.J., SHEPERD N.A. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus : a comparative study. J. Pathol., 1999, 187 : 535-540.
30. VAN SANDICK J.W., BAAK J.P., VAN LANSCHOT J.J., POLKOWSKI W., TEN KATE F.J., OBERTOP H., OFFERHAUS G.J. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus. J. Pathol., 2000, 190 : 177-183
31. HALM U., TANNAPFEL A., BREITUNG B., BREIDERT M., WITTEKIND C.W., MÖSSNER J. Apoptosis and cell proliferation in the metaplasia-dysplasia- carcinoma sequence of Barrett's oesophagus Hepatogastroenterol., 2000, 47 : 962-966.
32. SKACEL M., PETRAS R., RYBICKI L., GRAMLICH T.L., RICHTER J.E., FALK G.W., GOLDBLUM J.R. p53 expression in Low grade dysplasia in Barret's esophagus. Correlation with interobserver agreement and disease progression. Am. J. Gastroenterol., 2002, 97 : 2508-2513.
33. WESTON A.P., BANERJEE S.K., SHARMA P., TRANG M., TRAN M., RICHARDS R., CHERIAN R. p53 protein overexpression in LGD in Barrett's esophagus : immunhistochemical marker predictive of progression. Am. J. Gastroenterol., 2001, 96 : 1355-1362.
34. YOUNES M., ERTAN A., LECHAGO LV., SOMOANO J.R., LECHAGO J. p53 protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig. Dis. Sci., 1997, 42 : 697-701.
35. MURRAY L., SEDO A., SCOTT M., Mc MANUS D., SLOAN J.M., HARDIE L.J., FORMAN D., WILD C.P. TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort. Gut, 2006, 55 : 1390-1397.
36. KERKHOF M., STEVERBERG E.W., KUSTERS J.G., VAN DEKKEN H., VAN VUUREN A.J., KUIPERS E.J., SIERSEMA P.D. Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer Biomarkers, 2008, 4 : 1-10.
37. DORER R., ODZE R.D. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, Ulcerative colitis and Crohn's disease. Am. J. Surg. Pathol., 2006, 30 : 871-877.
38. LISOVSKY M., FALKOWSKI O., BHUIYA T. Expression of alpha methylacyl coenzyme A racemase in dysplastic Barrett's epithelium. Hum. Pathol., 2006, 37 : 1601-1606.
39. SCHEIL-BERTRAM S., LORENZ D., ELL C., SHEREMET E., FISSELER-ECKHOFF A. Expression of alpha methylacyl coenzyme A racemase in the dysplasia carcinoma sequence associated with Barrett's esophagus. Mod. Pathol., 2008, 21 : 961-967.
40. STRÄTER J., WIESMÜLLER C., PERNER S., KUEFER R., MÖLLER P. Alpha methylacyl coA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa : only significant overexpression favours a diagnosis of intraepithelial neoplasia. Histopathology, 2008, 52 : 399-402.
41. SHI X.Y., BHAGWANDEEN B., LEONG A. p16, Cyclin DI, KI67 and AMACR as markers for dysplasia in Barrett esophagus. Appl. Immunohistochem. Mol. Morph., 2008, 16 : 447-452.
42. HO MINH DUC K., SEMPOUX C., PIESSEVAUX H., DEPREZ P., JOURET-MOURIN A. Usefulness of p53 and p504S (racemase) in diagnosing Barrett's intraepithelial neoplasia. Acta Gastroenterol Belg., 2009, 72 : P 08.